» Articles » PMID: 28567440

Brazilian Attenuated Hyperglycemia, Dyslipidemia, and Prooxidant Status in Alloxan-Induced Diabetic Rats

Abstract

has been used popularly for several proposes, including diabetic. In an attempt to support medicinal value, the acute hypoglycemic, hypolipidemic, and antioxidant effects of the ethanolic extract of (EEMn 200 or 400 mg/kg b.w.) were evaluated in normal and alloxan-induced diabetic treated for 14 days. Serum biochemical and antioxidant analysis were performed at the end of experiment. Oral glucose tolerance test was performed at 10th and 15th days. Chromatographic analysis by HPLC-DAD of EEMn was performed. Insulin was used as positive control to glycemic metabolism as well as fenofibrate to lipid metabolism. EEMn (400 mg/kg/day) reduced fasting and postprandial glycaemia, improved oral glucose tolerance, and reduced lipolysis and proteolysis in diabetic rats. EEMn decreased the blood levels of total cholesterol and increased HDL level when compared to the diabetic control rats. At higher levels, EEMn reduced triglycerides and VLDL levels in diabetic rats. Also, EEMn reduced malondialdehyde and increased the reduced glutathione levels in liver of diabetic rats. Chromatographic analysis identified the presence of the flavonoids rutin, isoquercetin, and kaempferitrin. Acute EEMn treatment reduced hyperglycemia, improved oral glucose tolerance, and minimized dyslipidemia and oxidative stress leading to a reduction in atherogenic index in alloxan-induced diabetic rats.

Citing Articles

Hyperglycemia-associated Alzheimer's-like symptoms and other behavioral effects attenuated by L. Extract in alloxan-induced diabetic rats.

Naz S, Imran I, Farooq M, Shah S, Ajmal I, Zahra Z Front Pharmacol. 2023; 13:1077570.

PMID: 36588726 PMC: 9800837. DOI: 10.3389/fphar.2022.1077570.


Chronically administered . marginata extract ameliorates diabetes mellitus, associated behavioral comorbidities and biochemical parameters in alloxan-induced diabetic rats.

Aleem A, Shahnaz S, Javaid S, Ashraf W, Rasool M, Ahmad T Saudi Pharm J. 2022; 30(10):1373-1386.

PMID: 36387342 PMC: 9649343. DOI: 10.1016/j.jsps.2022.06.003.


Attenuation of carbohydrate metabolism and lipid profile by methanolic extract of Euphorbia helioscopia and improvement of beta cell function in a type 2 diabetic rat model.

Mustafa I, Anwar H, Irfan S, Muzaffar H, Ijaz M BMC Complement Med Ther. 2022; 22(1):23.

PMID: 35078449 PMC: 8790830. DOI: 10.1186/s12906-022-03507-2.


Nutraceutical and Medicinal Potential of the Species in Metabolic Dysfunctions.

Rodrigues E, Marcelino G, Silva G, Figueiredo P, Garcez W, Corsino J Int J Mol Sci. 2019; 20(2).

PMID: 30646503 PMC: 6358891. DOI: 10.3390/ijms20020301.

References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Patel D, Kumar R, Laloo D, Hemalatha S . Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed. 2013; 2(5):411-20. PMC: 3609313. DOI: 10.1016/S2221-1691(12)60067-7. View

3.
Matheus A, Tannus L, Cobas R, Palma C, Negrato C, Gomes M . Impact of diabetes on cardiovascular disease: an update. Int J Hypertens. 2013; 2013:653789. PMC: 3603160. DOI: 10.1155/2013/653789. View

4.
Imran M, Khan H, Shah M, Khan R, Khan F . Chemical composition and antioxidant activity of certain Morus species. J Zhejiang Univ Sci B. 2010; 11(12):973-80. PMC: 2997407. DOI: 10.1631/jzus.B1000173. View

5.
Anandh Babu P, Liu D, Gilbert E . Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem. 2013; 24(11):1777-89. PMC: 3821977. DOI: 10.1016/j.jnutbio.2013.06.003. View